Arjo AB (publ)
STO:ARJO B
Arjo AB (publ)
STO:ARJO B
Price:
25.5
SEK
-0.62%
Market Cap:
kr6.9B
Relative Value
The Relative Value of one
ARJO B
stock under the Base Case scenario is
50.55
SEK.
Compared to the current market price of 25.5 SEK,
Arjo AB (publ)
is
Undervalued by 50%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ARJO B
Relative Value
Base Case
50.55
SEK
Undervaluation 50%
Multiples Across Competitors
ARJO B Competitors Multiples
Arjo AB (publ) Competitors
Arjo AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Arjo AB (publ)
STO:ARJO B
|
6.9B SEK | 0.6 | 20.7 | 4.9 | 11.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.9B USD | 4.3 | 29.3 | 16.8 | 23 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.7B USD | 17.1 | 60.1 | 45.6 | 56 | |
| US |
|
Stryker Corp
NYSE:SYK
|
133.7B USD | 5.3 | 41.2 | 21 | 25.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.2B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.2B EUR | 1.9 | 20.7 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 8 | 45.2 | 24.9 | 27.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.7B USD | 10.9 | 44.1 | 31.3 | 34.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.6B USD | 2.1 | 26 | 10.2 | 17.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD | 6.2 | 22.6 | 15.9 | 17.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
